Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
University of Bergen
- License Information
-
More Information
Article History
Received: 9 April 2025
Accepted: 21 August 2025
First Online: 25 September 2025
Declarations
:
: AB is listed as an inventor on a patent relating to WO 2017/059864 held by the University of Southern Denmark and Aarhus University. AB has a financial interest in GlyProVac ApS, which has exclusively licensed the IP stated above. AB is the scientific founder and shareholder. AB is an employee of GlyProVac ApS, and KH is a member of the GlyProVac scientific advisory board. Other authors declare no conflict of interest.
